In this issue:
Similar effectiveness of infliximab and biosimilar in real-world use for HS
Global harmonisation of morphological definitions for a proposed glossary
Potential predictive biomarkers of adalimumab response in HS
Patients report high levels of satisfaction with topical 15% resorcinol treatment
Full exome sequencing of 11 families with HS
Efficacy of non-surgical monotherapies
Symptom improvements found with weight loss, smoking cessation and other lifestyle modifications
Characterising perimenstrual flares of HS
The impact of major life stages involving hormonal changes in women on HS
cSCC is a rare but serious complication of HS
Please login below to download this issue (PDF)